Treasury and the IRS released guidance today (IR-2026-45) for state governors on how to nominate census tracts for a new round of Qualified Opportunity Zone designations under OBBB.
For most healthcare pros, "Opportunity Zone" landed in the vocabulary back in 2018 when the first round was created, peaked around 2020-2021 when the marketing reached saturation, and quietly faded as some of the original tracts underperformed the institutional capital that rushed into them.
OZ 2.0 is different in a few important ways. The new tract nominations matter more than the headlines suggest.
The structural setup: an Opportunity Zone is a census tract where the federal government incentivizes long-term capital investment by allowing investors to defer (and partially eliminate) capital gains taxes if they redeploy those gains into qualifying property and hold for the prescribed period.
For a healthcare household, the relevance is specific. If you've had a liquidity event — practice sale, vested stock, inherited brokerage position — the standard path is to pay the capital gains tax and move on. OZ designations create a third option: defer the gains by redeploying into operator-controlled small commercial real estate in nominated tracts.
The first round produced both winners and duds. Some tracts saw real revitalization. Others became repositories for institutional capital chasing the tax benefit without the operational discipline to make the underlying real estate work. The second round has a chance to be cleaner. The lessons are visible now.
Two things worth watching as governors submit nominations through the year:
Which census tracts your state nominates. Many will be defensible. Some will be politically driven and structurally weak. The list is public when it lands. Worth reviewing your home state and any markets you operate in.
Whether your specific situation actually warrants OZ structuring. Most don't. Deferring capital gains is valuable in the right context and overengineered in the wrong one. The math depends on your basis, your gain, your timeline, and your risk tolerance. Not a strategy to chase. A tool to evaluate if you have a specific gain looking for a home.
For most readers, this is "watch the space, don't react yet." For a smaller subset — physicians or dentists planning a practice sale in the next 24 months, or sitting on a meaningful unrealized gain looking for a redeployment target — the new nominations open up a real question to bring to your CPA and a qualified real estate attorney.
Marketing on OZ 2.0 will arrive fast. The institutional funds are already drafting decks. Be a careful buyer. Or better: be your own buyer in a tract you understand.
— John